ThermoGenesis Holdings Inc (THMO) – Strategy, SWOT and Corporate Finance Report

ThermoGenesis Holdings Inc (THMO) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

ThermoGenesis Holdings Inc (ThermoGenesis), formerly Cesca Therapeutics Inc, researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its offers AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. ThermoGenesis is headquartered in Rancho Cordova, California, the US.

Scope

• Detailed information on ThermoGenesis Holdings Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ThermoGenesis Holdings Inc in the form of a SWOT analysis

• An in-depth view of the business model of ThermoGenesis Holdings Inc including a breakdown and examination of key business segments

• News about ThermoGenesis Holdings Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ThermoGenesis Holdings Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ThermoGenesis Holdings Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ThermoGenesis Holdings Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

U.S. Stem Cell Inc

Osiris Therapeutics Inc

Tissue Genesis Inc

Juventas Therapeutics Inc

GenVec, Inc.

Athersys Inc

Plus Therapeutics Inc

Vericel Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ThermoGenesis Holdings Inc - Key Facts

ThermoGenesis Holdings Inc - Key Employees

ThermoGenesis Holdings Inc - Key Employee Biographies

ThermoGenesis Holdings Inc - Major Products and Services

ThermoGenesis Holdings Inc - History

ThermoGenesis Holdings Inc - Company Statement

ThermoGenesis Holdings Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

ThermoGenesis Holdings Inc - Business Description

Product Category: Device Revenue

Performance

Product Category: Other

Performance

Product Category: Service Revenue

Performance

R&D Overview

ThermoGenesis Holdings Inc - Corporate Strategy

ThermoGenesis Holdings Inc - SWOT Analysis

SWOT Analysis - Overview

ThermoGenesis Holdings Inc - Strengths

ThermoGenesis Holdings Inc - Weaknesses

ThermoGenesis Holdings Inc - Opportunities

ThermoGenesis Holdings Inc - Threats

ThermoGenesis Holdings Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

ThermoGenesis Holdings Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 15, 2023: ThermoGenesis Holdings announces Q1 2023 financial results and provides corporate update

May 10, 2023: ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

Mar 30, 2023: ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update

Mar 28, 2023: ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update

Mar 15, 2023: ThermoGenesis announces roll out of ReadyStart cGMP suites for early-stage cell and gene therapy companies

Sep 30, 2022: ThermoGenesis Holdings announces financial results for the third quarter ended september 30, 2022 and provides corporate update

Aug 11, 2022: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update

Aug 09, 2022: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update

May 19, 2022: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update

May 18, 2022: ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide a Corporate Strategic Update

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ThermoGenesis Holdings Inc, Key Facts

ThermoGenesis Holdings Inc, Key Employees

ThermoGenesis Holdings Inc, Key Employee Biographies

ThermoGenesis Holdings Inc, Major Products and Services

ThermoGenesis Holdings Inc, History

ThermoGenesis Holdings Inc, Other Locations

ThermoGenesis Holdings Inc, Subsidiaries

ThermoGenesis Holdings Inc, Key Competitors

ThermoGenesis Holdings Inc, Ratios based on current share price

ThermoGenesis Holdings Inc, Annual Ratios

ThermoGenesis Holdings Inc, Annual Ratios (Cont…1)

ThermoGenesis Holdings Inc, Annual Ratios (Cont…2)

ThermoGenesis Holdings Inc, Interim Ratios

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

ThermoGenesis Holdings Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ThermoGenesis Holdings Inc, Performance Chart (2018 – 2022)

ThermoGenesis Holdings Inc, Ratio Charts

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

ThermoGenesis Holdings Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports